View Older Stories View More Recent Stories

Mar 6, 2017 09:00AM Andy Bass to Lead Biological & Popular Culture, Intrexon's Consumer Sector
Mar 1, 2017 05:10PM Intrexon Announces Fourth Quarter and Full Year 2016 Financial Results
Feb 23, 2017 08:00AM Fibrocell Announces Dosing of First Patient in Phase I/II Clinical Trial of FCX-007 Gene Therapy for Treatment of Recessive Dystrophic Epidermolysis Bullosa
Feb 22, 2017 08:00AM Intrexon to Announce Fourth Quarter and Full Year 2016 Financial Results on March 1st
Feb 13, 2017 08:00AM Lt. Gen. (Ret.) Thomas P. Bostick, Head of Intrexon's Environment Sector, Elected to National Academy of Engineering
Jan 26, 2017 08:00AM Exemplar Genetics Awarded Subcontract to Advance New Therapeutic Models for Sickle Cell Disease
Jan 24, 2017 09:02AM Intrexon (XON) to Acquire GenVec (GNVC)
Jan 24, 2017 09:00AM Intrexon to Acquire GenVec to Expand Industry-Leading Gene Delivery Platform
Jan 23, 2017 07:00AM Oxitec and GBIT Announce Launch of Friendly™ Aedes Project in India
Jan 12, 2017 08:04AM Intrexon (XON) Announces "When-Issued" Trading of Spin-Off AquaBounty (AQB)
Jan 12, 2017 08:00AM Intrexon Announces "When-Issued" Trading of AquaBounty Technologies In Connection With Special Stock Dividend of Shares
Jan 10, 2017 08:00AM ZIOPHARM and Intrexon Announce Cooperative Research and Development Agreement with the National Cancer Institute Utilizing Sleeping Beauty System to Generate T cells Targeting Neoantigens
Jan 5, 2017 08:04AM Fibrocell Science (FCSC) Receives FDA Fast Track Designation of FCX-007 for Treatment of RDEB
Jan 5, 2017 08:00AM Fibrocell Announces FDA Fast Track Designation of FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa
Jan 3, 2017 08:00AM Intrexon to Present at the 35th Annual J.P. Morgan Healthcare Conference
Dec 29, 2016 08:48AM Intrexon (XON) Announces Special Stock Dividend of AquaBounty Technologies Shares
Dec 29, 2016 08:45AM Intrexon Announces a Special Stock Dividend of Shares of AquaBounty Technologies
Dec 19, 2016 08:00AM Fibrocell Announces Leadership Changes
Dec 13, 2016 08:08AM Intrexon (XON) Advances ActoBiotics to Development Phase
Dec 13, 2016 08:00AM Intrexon Advances ActoBiotics™ Platform to Development Phase for Biological Crop Protection
Dec 12, 2016 08:00AM Oxitec's Medfly Ready for Open Field Trials
Nov 30, 2016 07:03AM Oxitec Announces Friendly™ Aedes Project is Supported By 92.8% of Piracicaba’s Population
Nov 21, 2016 09:03AM Oxitec Announces FKMCD Approval of Self-Limiting Friendly Use (XON)
Nov 21, 2016 09:00AM Board of Florida Keys Mosquito Control District Approves Investigational Agreement for Effectiveness Trial of Oxitec's Friendly™ Mosquitoes in Monroe County, Florida
Nov 11, 2016 08:00AM Intrexon to Present at the Stifel 2016 Healthcare Conference
Nov 10, 2016 08:39AM Fibrocell Science (FCSC) Names New Chief Medical Advisor
Nov 10, 2016 08:30AM Fibrocell Appoints Alfred T. Lane, MD, Chief Medical Advisor
Nov 9, 2016 04:05PM Intrexon Announces Third Quarter 2016 Financial Results
Nov 9, 2016 08:03AM Intrexon (XON) Announces Monroe County Votes in Support of Trial Utilizing Oxitec's Genetically Engineered Mosquitoes
Nov 9, 2016 08:00AM Monroe County Votes in Support of Florida Keys Mosquito Control District Conducting an Effectiveness Trial Utilizing Oxitec’s Genetically Engineered Mosquitoes
Nov 3, 2016 08:00AM Fibrocell Reports Third Quarter 2016 Financial Results and Recent Operational Highlights
Nov 2, 2016 08:00AM Intrexon to Announce Third Quarter 2016 Financial Results on November 9th
Oct 31, 2016 04:01PM Fibrocell to Host Conference Call and Webcast on Thursday, November 3, 2016 to Discuss Third Quarter 2016 Financial Results and Recent Operational Highlights
Oct 26, 2016 07:40AM Intrexon's (XON) Oxitec Large Mosquito Production Facility in Brazil
Oct 26, 2016 07:00AM Oxitec Opens Large Scale Mosquito Production Facility in Brazil
Sep 29, 2016 08:00AM Fibrocell to Present at 2016 Cell & Gene Meeting on the Mesa
Sep 26, 2016 06:06PM Intrexon Grants Employment Inducement Award Pursuant to NYSE Rule 303A.08
Sep 26, 2016 08:00AM Lieutenant General (Ret.) Thomas P. Bostick to Lead Intrexon's Environment Sector
Sep 26, 2016 07:07AM Intrexon (XON) Unit Receives USDA Approval for Arctic Fuji Apple
Sep 26, 2016 07:00AM Arctic® Fuji Gains USDA Approval
Sep 23, 2016 08:45AM Intrexon (XON) Enters into Exclusive Channel Collaborations with Two Startups
Sep 23, 2016 08:00AM Intrexon to Develop Disease-Modifying Therapies in New Collaborations with Harvest Intrexon Enterprise Fund
Sep 19, 2016 08:07AM Fibrocell Science (FCSC) Completes Enrollment in NC1+ Cohort of Phase I/II Clinical Trial of FCX-007 to Treat RDEB
Sep 19, 2016 08:00AM Fibrocell Completes Enrollment in NC1+ Cohort of Phase I/II Clinical Trial of FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa
Sep 7, 2016 01:23PM Intrexon (XON) Announces Florida Request for Emergency Authorization to Combat Mosquitoes
Sep 7, 2016 01:21PM Florida Speaker-Designate and House Members Request Emergency Authorization to Combat Aedes aegypti Mosquitoes with Oxitec Technology
Sep 7, 2016 01:21PM Florida Speaker-Designate and House Members Request Emergency Authorization to Combat Aedes aegypti Mosquitoes with Oxitec Technology
Sep 6, 2016 09:00AM Oxitec and Piracicaba City Hall Start Release of Friendly™ Aedes
Aug 9, 2016 04:05PM Intrexon Announces Second Quarter and First Half 2016 Financial Results
Aug 8, 2016 04:30PM Fibrocell Announces Proposed Public Offering of Common Stock and Warrants
View More Recent Stories View Older Stories